1
|
Ortega M, Fábrega-García MM, Molina-García T, Gavara J, de Dios E, Pérez-Solé N, Marcos-Garcés V, Padilla-Esquivel JJ, Diaz A, Martinez-Dolz L, Jimenez-Navarro M, Rios-Navarro C, Bodí V, Ruiz-Saurí A. Novel Fibrillar and Non-Fibrillar Collagens Involved in Fibrotic Scar Formation after Myocardial Infarction. Int J Mol Sci 2024; 25:6625. [PMID: 38928330 PMCID: PMC11204374 DOI: 10.3390/ijms25126625] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2024] [Revised: 05/30/2024] [Accepted: 06/11/2024] [Indexed: 06/28/2024] Open
Abstract
Following myocardial infarction (MI), adverse remodeling depends on the proper formation of fibrotic scars, composed of type I and III collagen. Our objective was to pinpoint the participation of previously unreported collagens in post-infarction cardiac fibrosis. Gene (qRT-PCR) and protein (immunohistochemistry followed by morphometric analysis) expression of fibrillar (types II and XI) and non-fibrillar (types VIII and XII) collagens were determined in RNA-sequencing data from 92 mice undergoing myocardial ischemia; mice submitted to permanent (non-reperfused MI, n = 8) or transient (reperfused MI, n = 8) coronary occlusion; and eight autopsies from chronic MI patients. In the RNA-sequencing analysis of mice undergoing myocardial ischemia, increased transcriptomic expression of collagen types II, VIII, XI, and XII was reported within the first week, a tendency that persisted 21 days afterwards. In reperfused and non-reperfused experimental MI models, their gene expression was heightened 21 days post-MI induction and positively correlated with infarct size. In chronic MI patients, immunohistochemistry analysis demonstrated their presence in fibrotic scars. Functional analysis indicated that these subunits probably confer tensile strength and ensure the cohesion of interstitial components. Our data reveal that novel collagens are present in the infarcted myocardium. These data could lay the groundwork for unraveling post-MI fibrotic scar composition, which could ultimately influence patient survivorship.
Collapse
Affiliation(s)
- María Ortega
- INCLIVA Biomedical Research Institute, 46100 Valencia, Spain; (M.O.); (T.M.-G.); (N.P.-S.); (V.M.-G.); (A.R.-S.)
| | | | - Tamara Molina-García
- INCLIVA Biomedical Research Institute, 46100 Valencia, Spain; (M.O.); (T.M.-G.); (N.P.-S.); (V.M.-G.); (A.R.-S.)
| | - Jose Gavara
- Centro de Biomateriales e Ingeniería Tisular, Universidad Politécnica de Valencia, 46022 Valencia, Spain;
- Centro de Investigación Biomédica en Red (CIBER)-CV, 28029 Madrid, Spain; (E.d.D.); (L.M.-D.); (M.J.-N.)
| | - Elena de Dios
- Centro de Investigación Biomédica en Red (CIBER)-CV, 28029 Madrid, Spain; (E.d.D.); (L.M.-D.); (M.J.-N.)
| | - Nerea Pérez-Solé
- INCLIVA Biomedical Research Institute, 46100 Valencia, Spain; (M.O.); (T.M.-G.); (N.P.-S.); (V.M.-G.); (A.R.-S.)
- Centro de Investigación Biomédica en Red (CIBER)-CV, 28029 Madrid, Spain; (E.d.D.); (L.M.-D.); (M.J.-N.)
| | - Víctor Marcos-Garcés
- INCLIVA Biomedical Research Institute, 46100 Valencia, Spain; (M.O.); (T.M.-G.); (N.P.-S.); (V.M.-G.); (A.R.-S.)
- Centro de Investigación Biomédica en Red (CIBER)-CV, 28029 Madrid, Spain; (E.d.D.); (L.M.-D.); (M.J.-N.)
- Cardiology Department, Hospital Clínico Universitario, 46010 Valencia, Spain
| | | | - Ana Diaz
- Unidad Central de Investigación Médica, University of Valencia, 46010 Valencia, Spain;
| | - Luis Martinez-Dolz
- Centro de Investigación Biomédica en Red (CIBER)-CV, 28029 Madrid, Spain; (E.d.D.); (L.M.-D.); (M.J.-N.)
- Cardiology Departament, Hospital Universitario Politécnico La Fe, 46026 Valencia, Spain
- Instituto de Investigación Sanitaria La Fe, 46026 Valencia, Spain
| | - Manuel Jimenez-Navarro
- Centro de Investigación Biomédica en Red (CIBER)-CV, 28029 Madrid, Spain; (E.d.D.); (L.M.-D.); (M.J.-N.)
- Servicio de Cardiología y Cirugía Cardiovascular-Área del Corazón, Hospital Universitario Virgen de la Victoria, 29010 Málaga, Spain
- Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina (IBIMA Plataforma BIONAND), 29590 Málaga, Spain
- Departamento de Medicina y Dermatología, Facultad de Medicina, Universidad de Málaga, 29010 Málaga, Spain
| | - Cesar Rios-Navarro
- INCLIVA Biomedical Research Institute, 46100 Valencia, Spain; (M.O.); (T.M.-G.); (N.P.-S.); (V.M.-G.); (A.R.-S.)
- Department of Pathology, University of Valencia, 46010 Valencia, Spain;
- Centro de Investigación Biomédica en Red (CIBER)-CV, 28029 Madrid, Spain; (E.d.D.); (L.M.-D.); (M.J.-N.)
| | - Vicente Bodí
- INCLIVA Biomedical Research Institute, 46100 Valencia, Spain; (M.O.); (T.M.-G.); (N.P.-S.); (V.M.-G.); (A.R.-S.)
- Centro de Investigación Biomédica en Red (CIBER)-CV, 28029 Madrid, Spain; (E.d.D.); (L.M.-D.); (M.J.-N.)
- Cardiology Department, Hospital Clínico Universitario, 46010 Valencia, Spain
- Department of Medicine, University of Valencia, 46010 Valencia, Spain
| | - Amparo Ruiz-Saurí
- INCLIVA Biomedical Research Institute, 46100 Valencia, Spain; (M.O.); (T.M.-G.); (N.P.-S.); (V.M.-G.); (A.R.-S.)
- Department of Pathology, University of Valencia, 46010 Valencia, Spain;
- Centro de Investigación Biomédica en Red (CIBER)-CV, 28029 Madrid, Spain; (E.d.D.); (L.M.-D.); (M.J.-N.)
| |
Collapse
|
2
|
Moradikhah F, Shabani I, Tafazzoli Shadpour M. Fabrication of a tailor-made conductive polyaniline/ascorbic acid-coated nanofibrous mat as a conductive and antioxidant cell-free cardiac patch. Biofabrication 2024; 16:035004. [PMID: 38507809 DOI: 10.1088/1758-5090/ad35e9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2023] [Accepted: 03/20/2024] [Indexed: 03/22/2024]
Abstract
Polyaniline (PANI) wasin-situpolymerized on nanofibrous polycaprolactone mats as cell-free antioxidant cardiac patches (CPs), providing electrical conductivity and antioxidant properties. The fabricated CPs took advantage of intrinsic and additive antioxidant properties in the presence of PANI backbone and ascorbic acid as a biocompatible dopant of PANI. The antioxidant nature of CPs may reduce the serious repercussions of oxidative stress, produced during the ischemia-reperfusion (I/R) process following myocardial infarction. The polymerization parameters were considered as aniline (60 mM, 90 mM, and 120 mM), ascorbic acid concentrations ([aniline]:[ascorbic acid] = 3:0, 3:0.5, 3:1, 3:3), and polymerization time (1 h and 3 h). Mainly, the more aniline concentrations and polymerization time, the less sheet resistance was obtained. 1,1 diphenyl-2-picrylhydrazyl (DPPH) assay confirmed the dual antioxidant properties of prepared samples. The advantage of the employedin-situpolymerization was confirmed by the de-doping/re-doping process. Non-desirable groups were excluded based on their electrical conductivity, antioxidant properties, and biocompatibility. The remained groups protected H9c2 cells against oxidative stress and hypoxia conditions. Selected CPs reduced the intracellular reactive oxygen species content and mRNA level of caspase-3 while the Bcl-2 mRNA level was improved. Also, the selected cardiac patch could attenuate the hypertrophic impact of hydrogen peroxide on H9c2 cells. Thein vivoresults of the skin flap model confirmed the CP potency to attenuate the harmful impact of I/R.
Collapse
Affiliation(s)
- Farzad Moradikhah
- Department of Biomedical Engineering, Amirkabir University of Technology, 1591634311 Tehran, Iran
| | - Iman Shabani
- Department of Biomedical Engineering, Amirkabir University of Technology, 1591634311 Tehran, Iran
| | | |
Collapse
|
3
|
Blázquez-Bujeda Á, Ortega M, de Dios E, Gavara J, Perez-Solé N, Molina-Garcia T, Marcos-Garcés V, Diaz A, Chorro FJ, Rios-Navarro C, Bodí V, Ruiz-Sauri A. Changes in the extracellular matrix at microvascular obstruction area after reperfused myocardial infarction: A morphometric study. Ann Anat 2023; 250:152138. [PMID: 37506775 DOI: 10.1016/j.aanat.2023.152138] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2022] [Revised: 07/03/2023] [Accepted: 07/12/2023] [Indexed: 07/30/2023]
Abstract
BACKGROUND Extracellular matrix (ECM) suffers substantial alterations after myocardial infarction (MI), including the invasion of leukocyte subtypes. Despite a complete reopening at epicardial level, hypoperfusion within the infarcted myocardium, known as microvascular obstruction (MVO), occurs and exerts a negative impact on ventricular remodeling. In this study, ECM composition at MVO regions was described using a morphometric analysis. METHODS MI was induced in female swine (n = 10) by transitory 90-minute coronary occlusion followed by seven days of reperfusion. Prior to euthanasia, intracoronary thioflavin-S was infused. Within the infarcted myocardium, regions displaying MVO (thioflavin-S-) or no MVO (thioflavin-S+) were isolated and stained to morphometrically compare ECM composition. RESULTS As reflected by cell invasion through ECM, areas with MVO displayed an enlarged presence of neutrophils and lymphocytes, whilst no differences in the amount of macrophages and myofibroblasts were detected compared to infarcted myocardium without MVO. Indeed, those regions with macroscopic MVO showed lower capillary density than areas without MVO. Lastly, a significant reduction in the extension of total collagen, type I, but not type III, collagen, laminin, and fibronectin together with an augmentation of polysaccharides were noted in areas showing MVO compared to those without microvascular injury. CONCLUSIONS ECM composition in infarcted regions with MVO isolated from female swine displays a higher presence of inflammatory infiltrate and polysaccharides as well as reduced number of microvessels and collagen content compared to those areas without microvascular hypoperfusion. These characteristics might underlie the development of adverse ventricular remodeling in MI patients with extensive MVO.
Collapse
Affiliation(s)
| | - Maria Ortega
- INCLIVA Health Research Institute, Valencia, Spain
| | - Elena de Dios
- Department of Medicine, Universidad de Valencia, Valencia, Spain; Centro de Investigación Biomédica en Red (CIBER)-CV, Madrid, Spain
| | - Jose Gavara
- Centro de Biomateriales e Ingeniería Tisular, Universidad Politécnica de Valencia, Valencia, Spain
| | | | | | - Victor Marcos-Garcés
- INCLIVA Health Research Institute, Valencia, Spain; Cardiology Department, Hospital Clinico Universitario, Valencia, Spain
| | - Ana Diaz
- Unidad Central de Investigación Biomédica, Universidad de Valencia, Valencia, Spain
| | - Francisco J Chorro
- INCLIVA Health Research Institute, Valencia, Spain; Department of Medicine, Universidad de Valencia, Valencia, Spain; Centro de Investigación Biomédica en Red (CIBER)-CV, Madrid, Spain; Cardiology Department, Hospital Clinico Universitario, Valencia, Spain
| | - Cesar Rios-Navarro
- Department of Pathology, Universidad de Valencia, Valencia, Spain; INCLIVA Health Research Institute, Valencia, Spain.
| | - Vicente Bodí
- INCLIVA Health Research Institute, Valencia, Spain; Department of Medicine, Universidad de Valencia, Valencia, Spain; Centro de Investigación Biomédica en Red (CIBER)-CV, Madrid, Spain; Cardiology Department, Hospital Clinico Universitario, Valencia, Spain.
| | - Amparo Ruiz-Sauri
- Department of Pathology, Universidad de Valencia, Valencia, Spain; INCLIVA Health Research Institute, Valencia, Spain
| |
Collapse
|
4
|
Ortega M, Ríos-Navarro C, Gavara J, de Dios E, Perez-Solé N, Marcos-Garcés V, Ferrández-Izquierdo A, Bodí V, Ruiz-Saurí A. Meta-Analysis of Extracellular Matrix Dynamics after Myocardial Infarction Using RNA-Sequencing Transcriptomic Database. Int J Mol Sci 2022; 23:ijms232415615. [PMID: 36555255 PMCID: PMC9779146 DOI: 10.3390/ijms232415615] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2022] [Revised: 12/05/2022] [Accepted: 12/07/2022] [Indexed: 12/13/2022] Open
Abstract
Extracellular matrix (ECM) changes after myocardial infarction (MI) need precise regulation, and next-generation sequencing technologies provide omics data that can be used in this context. We performed a meta-analysis using RNA-sequencing transcriptomic datasets to identify genes involved in post-MI ECM turnover. Eight studies available in Gene Expression Omnibus were selected following the inclusion criteria. We compare RNA-sequencing data from 92 mice submitted to permanent coronary ligation or sham, identifying differentially expressed genes (p-value < 0.05 and Log2FoldChange ≥ 2). Functional enrichment analysis was performed based on Gene Ontology biological processes (BPs). BPs implicated in response to extracellular stimulus, regulation of ECM organization, and ECM disassembly were detected soon after ischemia onset. ECM disassembly occurred between days one to seven post-MI, compared with ECM assembly from day seven onwards. We identified altered mRNA expression of 19 matrix metalloproteinases and four tissue inhibitors of metalloproteinases at post-infarcted ECM remodeling and altered transcriptomic expression of 42 genes encoding 26 collagen subunits at the fibrotic stage. To our knowledge, this is the first meta-analysis using RNA-sequencing datasets to evaluate post-infarcted cardiac interstitium healing, revealing previously unknown mechanisms and molecules actively implicated in ECM remodeling post-MI, which warrant further validation.
Collapse
Affiliation(s)
- María Ortega
- INCLIVA health Research Institute, 46010 Valencia, Spain
| | | | - Jose Gavara
- Centro de Biomateriales e Ingeniería Tisular, Universidad Politécnica de Valencia, 46022 Valencia, Spain
| | - Elena de Dios
- Department of Medicine, University of Valencia,46010 Valencia, Spain
- Centro de Investigación Biomédica en Red (CIBER)-CV, 28029 Madrid, Spain
| | | | - Victor Marcos-Garcés
- INCLIVA health Research Institute, 46010 Valencia, Spain
- Cardiology Department, Hospital Clínico Universitario, 46010 Valencia, Spain
| | - Antonio Ferrández-Izquierdo
- INCLIVA health Research Institute, 46010 Valencia, Spain
- Department of Pathology, University of Valencia, 46010 Valencia, Spain
- Pathology Department, Hospital Clínico Universitario, 46010 Valencia, Spain
| | - Vicente Bodí
- INCLIVA health Research Institute, 46010 Valencia, Spain
- Department of Medicine, University of Valencia,46010 Valencia, Spain
- Centro de Investigación Biomédica en Red (CIBER)-CV, 28029 Madrid, Spain
- Cardiology Department, Hospital Clínico Universitario, 46010 Valencia, Spain
- Correspondence: ; Tel.: +34-96-3862658
| | - Amparo Ruiz-Saurí
- INCLIVA health Research Institute, 46010 Valencia, Spain
- Department of Pathology, University of Valencia, 46010 Valencia, Spain
| |
Collapse
|